![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Westphalen, C.B. 
ORCID: https://orcid.org/0000-0002-5310-3754; Martins-Branco, D. ORCID: https://orcid.org/0000-0002-7214-4818; Beal, J.R. ORCID: https://orcid.org/0000-0001-8898-0549; Cardone, C.; Coleman, N.; Schram, A.M.; Halabi, S.; Michiels, S. ORCID: https://orcid.org/0000-0002-6963-2968; Yap, C. ORCID: https://orcid.org/0000-0002-6715-2514; André, F.; Bibeau, F.; Curigliano, G. ORCID: https://orcid.org/0000-0003-1781-2518; Garralda, E. ORCID: https://orcid.org/0000-0002-4412-7842; Kummar, S.; Kurzrock, R. ORCID: https://orcid.org/0000-0003-4110-1214; Limaye, S.; Loges, S.; Marabelle, A. ORCID: https://orcid.org/0000-0002-5816-3019; Marchió, C.; Mateo, J.; Rodon, J. ORCID: https://orcid.org/0000-0001-6467-3632; Spanic, T.; Pentheroudakis, G. ORCID: https://orcid.org/0000-0002-6632-2462 und Subbiah, V. ORCID: https://orcid.org/0000-0002-6064-6837
(2024):
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.
In: Annals of Oncology, Bd. 35, Nr. 11: S. 936-953
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-5310-3754; Martins-Branco, D. ORCID: https://orcid.org/0000-0002-7214-4818; Beal, J.R. ORCID: https://orcid.org/0000-0001-8898-0549; Cardone, C.; Coleman, N.; Schram, A.M.; Halabi, S.; Michiels, S. ORCID: https://orcid.org/0000-0002-6963-2968; Yap, C. ORCID: https://orcid.org/0000-0002-6715-2514; André, F.; Bibeau, F.; Curigliano, G. ORCID: https://orcid.org/0000-0003-1781-2518; Garralda, E. ORCID: https://orcid.org/0000-0002-4412-7842; Kummar, S.; Kurzrock, R. ORCID: https://orcid.org/0000-0003-4110-1214; Limaye, S.; Loges, S.; Marabelle, A. ORCID: https://orcid.org/0000-0002-5816-3019; Marchió, C.; Mateo, J.; Rodon, J. ORCID: https://orcid.org/0000-0001-6467-3632; Spanic, T.; Pentheroudakis, G. ORCID: https://orcid.org/0000-0002-6632-2462 und Subbiah, V. ORCID: https://orcid.org/0000-0002-6064-6837
(2024):
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.
In: Annals of Oncology, Bd. 35, Nr. 11: S. 936-953
[PDF, 2MB]
Harbeck, N.; Iyer, S.; Turner, N.; Cristofanilli, M.; Ro, J.; André, F.; Loi, S.; Verma, S.; Iwata, H.; Bhattacharyya, H.; Theall, K. Puyana; Bartlett, C. H. und Loibl, S.
(2016):
Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial.
In: Annals of Oncology, Bd. 27, Nr. 6: S. 1047-1054